Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schultz

Showing results (541-550 of 563) with videos related to

Pageof 57
Sort By:
Gynecologic Oncology|April 24, 2024
Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor RegistriesAlexander T Nelson, Anne K Harris, Dave Watson, et al.
Nature Communications|April 14, 2026
Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adultsHyun-Sik Yang, Juliana A U Anzai, Wai-Ying Wendy Yau, et al.
Alzheimer'S Research & Therapy|January 16, 2021
Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker studyJustin S Sanchez, Bernard J Hanseeuw, Francisco Lopera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAnnie Li, Hannah M Klinger, Mabel Seto, et al.
JAMA Neurology|March 3, 2025
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-AnalysisGillian T Coughlan, Hannah M Klinger, Rory Boyle, et al.
Brain : a Journal of Neurology|March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageingJasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2024
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathiesMelissa R Perrino, Anirban Das, Sarah R Scollon, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegenerationRory Boyle, Diana L Townsend, Hannah M Klinger, et al.
Brain Informatics|January 27, 2025
Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Pageof 57

Showing results (541-550 of 563) with videos related to

Sort By:
Pageof 57
Gynecologic Oncology|April 24, 2024
Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor RegistriesAlexander T Nelson, Anne K Harris, Dave Watson, et al.
Nature Communications|April 14, 2026
Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adultsHyun-Sik Yang, Juliana A U Anzai, Wai-Ying Wendy Yau, et al.
Alzheimer'S Research & Therapy|January 16, 2021
Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker studyJustin S Sanchez, Bernard J Hanseeuw, Francisco Lopera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAnnie Li, Hannah M Klinger, Mabel Seto, et al.
JAMA Neurology|March 3, 2025
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-AnalysisGillian T Coughlan, Hannah M Klinger, Rory Boyle, et al.
Brain : a Journal of Neurology|March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageingJasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2024
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathiesMelissa R Perrino, Anirban Das, Sarah R Scollon, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegenerationRory Boyle, Diana L Townsend, Hannah M Klinger, et al.
Brain Informatics|January 27, 2025
Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Pageof 57